|
|||||
|
|
Serum levels of interleukin‐22 and hepatitis B core‐related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B |
|
| Authors: | Sadahisa Okuhara Takeji Umemura Satoru Joshita Soichiro Shibata Takefumi Kimura Susumu Morita Michiharu Komatsu Akihiro Matsumoto Kaname Yoshizawa Yoshihiko Katsuyama Masao Ota Eiji Tanaka |
| Affiliation: | 1. Department of Medicine, Division of Hepatology and Gastroenterology, , Matsumoto, Japan;2. Department of Pharmacy, Shinshu University Hospital, , Matsumoto, Japan;3. Department of Legal Medicine, Shinshu University School of Medicine, , Matsumoto, Japan |
| Abstract: | |
| Keywords: | entecavir hepatitis B core‐related antigen hepatitis B surface antigen hepatitis B virus interleukin‐22 |